{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:10:37Z","timestamp":1761487837198},"reference-count":73,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.vaccine.2007.04.084","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T11:54:13Z","timestamp":1179921253000},"page":"5175-5188","source":"Crossref","is-referenced-by-count":12,"title":["Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel","family":"Yero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Paj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusleydis","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildrey","family":"Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karem","family":"Cobas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiyana","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa L.","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2007.04.084_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2007.04.084_bib3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14712598.5.12.1611","article-title":"Towards an improved serogroup B Neisseria meningitidis vaccine","volume":"5","author":"Perrett","year":"2005","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.76.1.91","article-title":"Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides","volume":"76","author":"Peltola","year":"1985","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2007.04.084_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.293.12.1433","article-title":"New vaccine should ease meningitis fears","volume":"293","author":"Mitka","year":"2005","journal-title":"JAMA"},{"issue":"8346","key":"10.1016\/j.vaccine.2007.04.084_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.084_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"issue":"8775","key":"10.1016\/j.vaccine.2007.04.084_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib9","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"16","key":"10.1016\/j.vaccine.2007.04.084_bib10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2007.04.084_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","article-title":"Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2007.04.084_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nbt728","article-title":"Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays","volume":"20","author":"Grifantini","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.084_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"5459","key":"10.1016\/j.vaccine.2007.04.084_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"5459","key":"10.1016\/j.vaccine.2007.04.084_bib18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.vaccine.2007.04.084_bib19","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2007.04.084_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","article-title":"Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia","volume":"187","author":"Plested","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08830180109043034","article-title":"Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide","volume":"20","author":"Moe","year":"2001","journal-title":"Int Rev Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.04.084_bib22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2003.10.005","article-title":"Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers","volume":"22","author":"Bruge","year":"2004","journal-title":"Vaccine"},{"issue":"4 Pt. 2","key":"10.1016\/j.vaccine.2007.04.084_bib23","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1164\/ajrccm.162.supplement_3.15tac10","article-title":"Antigen presentation and DNA vaccines","volume":"162","author":"Donnelly","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.04.084_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0264-410X(96)00265-4","article-title":"Biological features of genetic immunization","volume":"15","author":"Barry","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.084_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"6550","key":"10.1016\/j.vaccine.2007.04.084_bib26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/377632a0","article-title":"Protection against mycoplasma infection using expression-library immunization","volume":"377","author":"Barry","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.163.3.1467","article-title":"Protective immune responses induced by vaccination with an expression genomic library of Leishmania major","volume":"163","author":"Piedrafita","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.04.084_bib28","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.084_bib29","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/IAI.73.5.2974-2985.2005","article-title":"Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine","volume":"73","author":"Scorza","year":"2005","journal-title":"Infect Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.04.084_bib30","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1128\/IAI.73.10.6877-6884.2005","article-title":"Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection","volume":"73","author":"Huntley","year":"2005","journal-title":"Infect Immunol"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2007.04.084_bib31","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1016\/S0264-410X(03)00485-7","article-title":"Identification of a protective antigen of Coccidioides immitis by expression library immunization","volume":"21","author":"Ivey","year":"2003","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2007.04.084_bib32","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/S0264-410X(02)00683-7","article-title":"Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization","volume":"21","author":"Almazan","year":"2003","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2007.04.084_bib33","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.vaccine.2004.12.013","article-title":"Screening the whole genome of a pathogen in vivo for individual protective antigens","volume":"23","author":"Stemke-Hale","year":"2005","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2007.04.084_bib34","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.vaccine.2005.12.035","article-title":"Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates","volume":"24","author":"Li","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.04.084_bib35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.vaccine.2004.07.032","article-title":"Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model","volume":"23","author":"Yero","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0882-4010(88)90070-8","article-title":"Experimental meningococcal meningitis in the infant rat","volume":"4","author":"Saukkonen","year":"1988","journal-title":"Microb Pathog"},{"issue":"17","key":"10.1016\/j.vaccine.2007.04.084_bib37","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucl Acids Res"},{"issue":"4","key":"10.1016\/j.vaccine.2007.04.084_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2004.05.028","article-title":"Improved prediction of signal peptides: signalP 3.0","volume":"340","author":"Bendtsen","year":"2004","journal-title":"J Mol Biol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.04.084_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tube.2006.01.005","article-title":"Computational identification of beta-barrel outer-membrane proteins in Mycobacterium tuberculosis predicted proteomes as putative vaccine candidates","volume":"86","author":"Pajon","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2007.04.084_bib40","doi-asserted-by":"crossref","first-page":"D192","DOI":"10.1093\/nar\/gki069","article-title":"CDD: a conserved domain database for protein classification","volume":"33","author":"Marchler-Bauer","year":"2005","journal-title":"Nucl Acids Res"},{"issue":"22","key":"10.1016\/j.vaccine.2007.04.084_bib41","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucl Acids Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib42","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib44","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/iai.29.3.886-891.1980","article-title":"Iron-controlled infection with Neisseria meningitidis in mice","volume":"29","author":"Holbein","year":"1980","journal-title":"Infect Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.04.084_bib45","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tibtech.2004.12.008","article-title":"The impact of genomics on vaccine design","volume":"23","author":"Scarselli","year":"2005","journal-title":"Trends Biotechnol"},{"issue":"5645","key":"10.1016\/j.vaccine.2007.04.084_bib47","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.1092329","article-title":"Reverse vaccinology and genomics","volume":"302","author":"Rappuoli","year":"2003","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.084_bib48","first-page":"575","article-title":"DNA microarrays in vaccine research","volume":"5","author":"Dietrich","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2007.04.084_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0105-2896.2004.00143.x","article-title":"Expression library immunization to discover and improve vaccine antigens","volume":"199","author":"Barry","year":"2004","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib50","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1128\/IAI.73.11.7089-7098.2005","article-title":"Expression library immunization: a road map for discovery of vaccines against infectious diseases","volume":"73","author":"Talaat","year":"2005","journal-title":"Infect Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.084_bib51","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.04.084_bib52","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/IAI.72.10.5903-5909.2004","article-title":"Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity","volume":"72","author":"Welsch","year":"2004","journal-title":"Infect Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib53","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.69.3.1561-1567.2001","article-title":"Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection","volume":"69","author":"West","year":"2001","journal-title":"Infect Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib54","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.04.084_bib55","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2005.01.053","article-title":"Experimental disease models for the assessment of meningococcal vaccines","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2007.04.084_bib56","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(99)00049-3","article-title":"The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci","volume":"17","author":"Toropainen","year":"1999","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2007.04.084_bib57","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.vaccine.2005.03.015","article-title":"Identification of novel antigens that protect against systemic meningococcal infection","volume":"23","author":"Sun","year":"2005","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.04.084_bib58","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib59","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.72.11.6511-6518.2004","article-title":"Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential","volume":"72","author":"O\u2019dwyer","year":"2004","journal-title":"Infect Immunol"},{"issue":"9091","key":"10.1016\/j.vaccine.2007.04.084_bib60","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.084_bib61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/IAI.63.3.884-890.1995","article-title":"Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines","volume":"63","author":"Lissolo","year":"1995","journal-title":"Infect Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib62","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.04.084_bib63","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.femsim.2004.11.013","article-title":"Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules","volume":"44","author":"Gioia","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.04.084_bib65","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1128\/IAI.67.5.2452-2463.1999","article-title":"Cellular immune responses to Neisseria meningitidis in children","volume":"67","author":"Pollard","year":"1999","journal-title":"Infect Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib66","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/pmic.200500502","article-title":"Outer membrane vesicles of the VA-MENGOC-BC(R) vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry","volume":"6","author":"Uli","year":"2006","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0134(199709)29:1<113::AID-PROT9>3.0.CO;2-G","article-title":"Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide","volume":"29","author":"van Den Elsen","year":"1997","journal-title":"Proteins"},{"issue":"Pt. 9","key":"10.1016\/j.vaccine.2007.04.084_bib68","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1099\/00221287-142-9-2491","article-title":"Immune responses to linear epitopes on the PorB protein of Neisseria meningitidis in patients with systemic meningococcal disease","volume":"142","author":"Delvig","year":"1996","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.04.084_bib69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"Giuliani","year":"2005","journal-title":"Infect Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.04.084_bib70","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.167.11.6487","article-title":"A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis","volume":"167","author":"Granoff","year":"2001","journal-title":"J Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.04.084_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/08830180600785827","article-title":"From plasmids to protection: a review of DNA vaccines against infectious diseases","volume":"25","author":"Laddy","year":"2006","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.vaccine.2007.04.084_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.04.084_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-842X(97)01145-1","article-title":"The role of CpG dinucleotides in DNA vaccines","volume":"6","author":"Krieg","year":"1998","journal-title":"Trends Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07005361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07005361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T23:21:21Z","timestamp":1683847281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07005361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":73,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0264410X07005361"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}